Saint Vincent and the Grenadines
8 Vaccines Approved for Use in Saint Vincent and the Grenadines
Protein Subunit
Center for Genetic Engineering and Biotechnology (CIGB)
Abdala
Approved in 6 countries
5 trials in 1 country
Approval Source: plenglish.com
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: health.gov.vc
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: health.gov.vc
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: loopnewscaribbean.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: health.gov.vc
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: health.gov.vc